The ubiquitin-conjugating DNA repair enzyme is a maternal factor essential for early embryonic development in mice by Roest, H.P. (Henk) et al.
MOLECULAR AND CELLULAR BIOLOGY, June 2004, p. 5485–5495 Vol. 24, No. 12
0270-7306/04/$08.000 DOI: 10.1128/MCB.24.12.5485–5495.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
The Ubiquitin-Conjugating DNA Repair Enzyme HR6A Is a Maternal
Factor Essential for Early Embryonic Development in Mice
Henk P. Roest,1,2† Willy M. Baarends,2 Jan de Wit,1 Jan W. van Klaveren,1 Evelyne Wassenaar,2
Jos W. Hoogerbrugge,2 Wiggert A. van Cappellen,2 Jan H. J. Hoeijmakers,1
and J. Anton Grootegoed2*
MGC-Department of Cell Biology and Genetics, Centre for Biomedical Genetics,1 and Department of
Reproduction and Development,2 Erasmus MC, Rotterdam, The Netherlands
Received 11 December 2003/Returned for modification 24 January 2004/Accepted 28 March 2004
The Saccharomyces cerevisiae RAD6 protein is required for a surprising diversity of cellular processes,
including sporulation and replicational damage bypass of DNA lesions. In mammals, two RAD6-related genes,
HR6A and HR6B, encode highly homologous proteins. Here, we describe the phenotype of cells and mice
deficient for the mHR6A gene. Just like mHR6B knockout mouse embryonic fibroblasts, mHR6A-deficient cells
appear to have normal DNA damage resistance properties, but mHR6A knockout male and female mice display
a small decrease in body weight. The necessity for at least one functional mHR6A (X-chromosomal) or mHR6B
(autosomal) allele in all somatic cell types is supported by the fact that neither animals lacking both proteins
nor females with only one intact mHR6A allele are viable. In striking contrast to mHR6B knockout males, which
show a severe spermatogenic defect, mHR6A knockout males are normally fertile. However, mHR6A knockout
females fail to produce offspring despite a normal ovarian histology and ovulation. The absence of mHR6A in
oocytes prevents development beyond the embryonic two-cell stage but does not result in an aberrant meth-
ylation pattern of histone H3 at this early stage of mouse embryonic development. These observations support
redundant but dose-dependent roles for HR6A and HR6B in somatic cell types and germ line cells in mammals.
Repair of damaged DNA requires a number of complemen-
tary, partially overlapping mechanisms, including mismatch re-
pair, nucleotide and base excision repair, and repair pathways
that deal with double-strand breaks. S-phase arrest caused by
unrepaired DNA damage is prevented by a mechanism known
as postreplication repair, which we prefer to rename replica-
tional damage bypass (RDB). This bypass mechanism allows
replication across lesions instead of repairing lesions (20, 26).
Based on the mutant phenotype, RAD6 is one of the key
players in RDB in yeast. rad6 mutants are extremely sensitive
to a wide range of DNA-damaging agents and show an in-
creased spontaneous mutation frequency and a loss of DNA
damage-induced mutagenesis (41, 46). In addition, RAD6 is
also involved in a number of other cellular processes in yeast,
including the degradation of proteins via the N-end rule, ret-
rotransposition, gene silencing, meiosis, and sporulation (14,
15, 28, 52). RAD6 was identified as a ubiquitin-conjugating
enzyme (29), and all of the functions of RAD6 in yeast depend
on its ability to transfer ubiquitin molecules to a protein sub-
strate (66). The ubiquitin-conjugating pathway requires the
consecutive activity of ubiquitin-activating (E1), -conjugating
(E2), and -ligating (E3) enzymes and results in mono- or poly-
ubiquitination of substrate proteins. The ubiquitination serves
as a signal for modification, activation, or proteolytic degrada-
tion via the 26S proteasome. The identification of 11 ubiquitin-
conjugating enzymes in yeast and at least 20 genes encoding
such proteins in the human genome, as well as the existence of
a vast number of E3s, suggests that high substrate specificity
can be obtained by combining different E2s and E3s (24).
RAD18, UBR1, and BRE1 are E3 proteins that interact with
RAD6 and are involved in RDB, degradation of proteins via
the N-end rule, and chromatin modification, respectively (7,
15, 77). Ubiquitination of histone H2B at lysine residue 123 by
RAD6 is essential for sporulation in yeast (54). Recently, it was
shown that ubiquitination of H2B is a prerequisite for the
methylation of histone H3 at specific lysine residues, with
BRE1 being the putative E3 involved in this process (11, 16, 48,
65). PCNA (proliferating cell nuclear antigen) has only re-
cently been identified as an important target for RAD6 and as
having relevance to the process of RDB and resistance to DNA
damage. The presence of a functional RAD18 is essential for
this (mono)ubiquitination (25). Mammals contain two RAD6-
homologous genes, designated HR6A and HR6B, encoding
152-amino-acid proteins that are structurally and functionally
highly conserved; the proteins share approximately 70% se-
quence identity with yeast RAD6 and around 95% identity
with each other (33). The mouse homologs mHR6A and
mHR6B are 100% identical to the human proteins hHR6A
and hHR6B, respectively. Both mammalian homologs are
ubiquitously expressed and are able to complement a rad6
mutant strain for repair and mutagenesis functions but not for
the sporulation defect which appears to depend on the acidic
tail that is present only in yeast RAD6 (31, 53).
Previously, the generation and characterization of mHR6B
knockout mice, the first animal model defective in the ubiq-
uitin-conjugating pathway, were described (55). The mHR6B
knockout mice show a male-limited sterility phenotype, with
spermatogenic derailment which is most pronounced during
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postmeiotic condensation of chromatin in elongating sperma-
tids (55). This step in spermatogenesis coincides with histone-
to-protamine replacement, essential for normal sperm devel-
opment. As was shown, the level of HR6B exceeds that of
HR6A in spermatids in rats and mice, which is in agreement
with an important role in postmeiotic cells (6, 32). In addition,
a defect in the meiotic prophase in spermatocytes of mHR6B
knockout male mice has been identified (6).
In the present report, we describe the effect of using gene
targeting in mice to inactivate the other RAD6 homolog,
mHR6A. In addition, we have evaluated the viability of mice
with different numbers of intact mHR6A and mHR6B alleles.
The results obtained are discussed with respect to the speci-
ficity and redundancy of the two encoded ubiquitin-conjugat-
ing enzymes.
MATERIALS AND METHODS
Isolation of cDNAs and genomic clones. A 1.7-kb human HR6A cDNA frag-
ment (33) was used to screen a ZAP mouse brain library (Stratagene, La Jolla,
Calif.). Out of a number of positive clones, we selected one (designated B4) that
contained an insert of approximately 1.7 kb and resembled the major transcript
detectable in all tissues (32). This cDNA was sequenced by using T7 polymerase
(Amersham Biosciences, Piscataway, N.J.) according to the manufacturer’s
guidelines. An EcoRI subclone encompassing the first 301 nucleotides was sub-
sequently used to screen an EMBL-3  phage-based 129Sv mouse genomic CCE
library. Two genomic clones were isolated. These clones were designated X2 and
X4, and both contained the complete gene.
Construction of the targeting vector and disruption of mHR6A in ES cells. A
5.26-kb ScaI fragment containing exons 1 to 3 was selected as the starting point
for a targeting construct and cloned in pIC20R (43). The resulting plasmid was
digested with SalI and BamHI, and a cassette containing the neomycin resistance
gene expressed under the control of the thymidine kinase promoter (69) was
inserted as a XhoI/BamHI fragment, thereby replacing the coding part of exon
1 with the dominant selectable marker (Fig. 1A). The resulting plasmid was
digested with Asp718I and EcoRV, and the insert was recovered from agarose by
electrophoresis. Approximately 10 g of DNA was electroporated into E14
embryonic stem (ES) cells (a kind gift of A. Berns, NKI, The Netherlands) as
described previously (81). Individual neomycin-resistant clones were picked and
expanded. Genomic DNA was isolated as described previously (39), digested
with EcoRI, and screened for homologous integration by Southern blot analysis.
Generation of mHR6A-deficient mice and fibroblasts. Individual ES clones
with the correct karyotype and a correctly integrated mHR6A-targeting construct
were injected into C57BL/6J blastocysts by using standard procedures (9). Male
chimeras were bred with wild-type female FVB/n animals, and germ line trans-
mission was recognized on the basis of a gray coat color of the offspring. Tail
DNA was isolated as described previously (39), digested, and analyzed by South-
ern blotting. Starting with the F2 generation, animals were genotyped by multi-
plex PCR. With primers mHR6A.7B (5-CTCGGCTCCGGAGCGGCAGT-3)
and mHR6A.3B (5-CCCTCATGAGGCGGCGCCGGG-3), a 153-bp fragment
representing the wild-type allele was amplified. Primers mHR6A.7B and
NEOAS (5-TAGCCGAATAGCCTCTCCACCC-3) resulted in the amplifica-
tion of a 462-nucleotide fragment representing the targeted allele. Primary
mouse embryonic fibroblasts (MEFs) were isolated as described elsewhere (71).
The UV sensitivity of MEFs was determined by assaying the incorporation of
[3H]thymidine at various doses of UV (61).
RNA isolation and RT PCR. Total RNA was isolated from testes by using
LiCl-urea (4), and cDNA was made by using 20 U of AMV-reverse transcriptase
(RT) (Promega Benelux, Leiden, The Netherlands) with random hexamer prim-
ers (Roche Diagnostics, Almere, The Netherlands) according to the manufac-
turer’s protocol in the presence of 40 U of RNAsin (Promega). mHR6A cDNA
was amplified by using forward primer mHR6A.7B in exon 1 and reverse primer
mHR6A.10 (5-TCATAGGTTGGACTCCAACGG-3) in exon 5.
Gel electrophoresis and immunoblotting. Two-dimensional gel electrophore-
sis was done essentially as described by O’Farrell et al. (49). In short, oocytes or
ovaria were sonicated in buffer A (0.5% [wt/vol] sodium dodecyl sulfate, 4 M
urea, 1 mM dithiothreitol [DTT], 1% [vol/vol] Nonidet P-40, 0.1% [vol/vol]
Bio-Lyte [pH 3 to 5; Bio-Rad, Veenendaal, The Netherlands], 0.1% [vol/vol]
Bio-Lyte [pH 4 to 6; Bio-Rad]) and spun at 4°C at 13,000 rpm for 10 min, and the
supernatant was collected. The protein concentration was determined by using
the bichinchoninic acid assay (Pierce, Rockford, Ill.). Protein lysates to be sep-
arated in the first dimension were diluted in solution B (9 M urea, 1% [vol/vol]
Bio-Lyte [pH 3 to 5], 1% [vol/vol] Bio-Lyte [pH 4 to 6], 1% Nonidet P-40, 100
mM DTT). Samples were boiled for 3 min and cooled on ice. Samples (40 l)
containing approximately 10 g of protein were loaded on gels consisting of 4%
acrylamide-bisacrylamide in solution B without DTT in 12-cm glass tubes. Sam-
ples were overlaid with 10 l of overlay buffer (8 M urea, 1% [vol/vol] Bio-Lyte
[pH 3 to 5], 1% [vol/vol] Bio-Lyte [pH 4 to 6]) and run for 16 h at 175 V in a
Bio-Rad 175 tube cell (Bio-Rad) with 0.02 M NaOH in the lower chamber
(cathode) and 0.01 M H3PO4 in the upper chamber (anode). After the first
dimension was run, gels were removed from the glass tubes and either directly
used for second-dimension polyacrylamide gel electrophoresis or stored at
20°C. Approximately 2 cm of the gel was cut off at the acidic side, and the rest
was equilibrated in sample buffer (10% [vol/vol] glycerol, 2% sodium dodecyl
sulfate, 10 mM DTT, 0.01% bromophenol blue, 62.5 mM Tris-HCl [pH 6.8]).
Equilibrated gels were placed on top of a 15% phosphonoacetic acid gel with a
4% stacking layer and electrophoresed by using the Mini Protean II system
(Bio-Rad, Hercules, Calif.). Subsequently, proteins were blotted on nitrocellu-
lose (0.45 m; Scleicher & Schull, Dassel, Germany), and mHR6A and mHR6B
were detected by using -HR6A/B antibody as described previously (5).
Superovulation of female mice and isolation of oocytes and embryos. To
isolate unfertilized oocytes for biochemical analysis, follicle growth in female
mice was induced by intraperitoneal injection of 5 IU of Folligonan (Intervet,
Boxmeer, The Netherlands). Forty-eight hours later, the mice were killed by
cervical dislocation and the ovaries were isolated. Isolated ovaries were put in
100-l drops of IVF medium [98.37 mM NaCl, 4.56 mM KCl, 0.69 mM MgSO4 
7H2O, 22.54 mM NaHCO3, 0.86 mM NaH2PO4  2H2O, 0.085% (wt/vol) glucose,
0.0581% (wt/vol) Ca-L()-lactate, and 0.1485% (wt/vol) powdered F-10 supple-
mented with pasteurized plasma solution (final concentration, 3.5 g/liter)] and
extensively punctured with two 30-gauge needles. Oocytes were collected and
washed once in fresh IVF medium, pelleted by a quick spin in a table centrifuge,
snap frozen, and stored at 80°C pending further use.
To obtain fertilized oocytes and preimplantation embryos, female mice were
injected intraperitoneally with 5 IU of Chorulon (Intervet) 48 h after Folligonan
injection and housed overnight with male mice. One-cell embryos (fertilized
oocytes up to and including the zygote stage), two-cell embryos, and blastocysts
were isolated from the oviduct or the uterus at 0.5, 1.5, and 3.5 days postcoitum
(dpc) (E0.5, E1.5, and E3.5), respectively, as described previously (27). E1.5-
stage embryos were placed in 50-l droplets of IVF medium under mineral oil in
a 5% CO2 incubator at 37°C and cultured for 72 h.
Immunofluorescence. One-cell-stage embryos were isolated as described
above, collected in phosphate-buffered saline (PBS), fixed in 4% paraformalde-
hyde in PBS for 8 min at room temperature, and subsequently permeabilized in
0.5% Triton X-100 in PBS for 8 min at room temperature. To reduce background
fluorescence, embryos were treated with 1% [wt/vol] bovine serum albumin in
PBS–0.5% Tween 20 (blocking reagent) for 30 min at room temperature. Pri-
mary antibody incubations in blocking reagent were carried out overnight at 4°C,
followed by three washes in blocking reagent at room temperature for 10 min.
Secondary antibodies were incubated for 2 h at room temperature in blocking
reagent, followed by three 10-min washes in blocking reagent at room temper-
ature in the dark. Embryos were mounted on slides in Vectashield (Vector
Laboratories, Burlingame, Calif.) containing DAPI (4,6-diamidino-2-phenyl-
indole). Images were taken with a fluorescence microscope (Axioplan 2; Carl
Zeiss, Jena, Germany) equipped with a digital camera (Coolsnap-Pro; Photo-
metrics, Waterloo, Canada).
Confocal imaging. Images were made with a confocal scanning laser micro-
scope (Zeiss LSM510NLO; Carl Zeiss). During the observation period, fertilized
oocytes were kept in a drop of IVF medium on a round cover glass mounted in
a special chamber. Observations were made by using a 63 oil immersion lens,
and fertilized oocytes were imaged in optical planes with a 2-m distance. DNA
was made visible by using the DNA vital stain Syto16 (Molecular Probes Europe
BV, Leiden, The Netherlands) added to the IVF medium. A 488-nm argon laser
was used for excitation, and the emission was measured with a band-pass filter
between 500 and 550 nm. Images were obtained by using the LSM510 image
software (Carl Zeiss).
Nucleotide sequence accession number. The B4 HR6A cDNA sequence was
submitted to GenBank/EMBL under accession no. AF089812.
RESULTS
Isolation and characterization of mouse mHR6A cDNA. To
isolate the mHR6A cDNA, we screened a mouse brain library
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with human cDNA as a probe. A mouse cDNA fragment of
1.7 kb, probably representing the major transcript (32), was
isolated. Sequencing revealed 73% sequence identity with the
human transcript overall and 93% sequence identity in the
putative open reading frame (ORF). The encoded gene prod-
uct, 152 amino acid residues long as translated from the sub-
mitted mouse sequence (GenBank accession no. AF089812),
was 100% identical in sequence to the protein specified by the
human cDNA from the public expressed sequence tag and
human genome project databases, underlining the importance
of this protein. In contrast to the 3 untranslated regions of
mHR6B and hHR6B, no stretch of conserved nucleotides
FIG. 1. Targeted disruption of the mHR6A gene by homologous recombination. (A) Genomic organization and disruption strategy for mHR6A;
shown are the gene, the targeting construct, and the targeted mHR6A allele. The neo cassette is inserted between the SalI site of exon 1 and the
BamHI site in the first intron, introducing a diagnostic EcoRI site. Note that the insertion of the dominant marker disrupts the gene immediately
behind the ATG translation initiation codon and deletes the coding part of exon 1. Shown are the relevant restriction sites (E, EcoRI; S, SalI; B,
BamHI; C, ScaI; X, XmnI; H, HinDIII; O, XhoI; A, Asp718I; V, EcoRV). The position of the 3 probe for Southern blot analysis is indicated above
the mutated locus. Lines at the top and bottom indicate the estimated lengths of the fragments detected in Southern blot analysis of EcoRI-
digested DNA. Roman numerals mark the exons. The 3 deletion of exon 1 in the targeted allele is indicated with an asterisk. (B) Southern analysis
of EcoRI-digested DNA from three neomycin-resistant ES clones after hybridization with the 3 probe. The positions of the wild-type allele (23.6
kb) and the targeted allele (7.3 kb) are indicated. Note that the male ES line contains only one X-chromosomal mHR6A gene copy. “/y” indicates
a homologous recombinant ES clone, and “/y” indicates a wild-type ES clone. The difference in signals between the targeted band and the
wild-type band is presumably due to difficulty in the transfer of large fragments. (C) PCR-based genotyping of nine littermates. Primers mHR6A.7B
and mHR6A.3B amplify a 152-bp fragment representing the wild-type allele (wt), and primers mHR6A.7B and NEOAS amplify a 473-nucleotide
fragment representing the targeted allele (ta). Note that male animals (/y and /y) possess only one allele due to the X-chromosomal location
of the allele. (D) RT PCR with total mouse testis RNA (lanes 1 to 4) from an mHR6A/Y animal (lanes 1 and 2) and an mHR6A/Y male littermate
(lanes 3 and 4). Reactions were performed in the absence (lanes 1 and 3) or in the presence (lanes 2, 4, and 5) of RT. Lane 5 contains no RNA.
M indicates the marker lane, with fragment lengths indicated on the right.
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was present in the 3 untranslated regions of mHR6A and
hHR6A, suggesting that this is a specific feature of the HR6B
gene (55).
Isolation of genomic sequences and targeting of ES cells.
Two overlapping clones of mouse strain 129Sv DNA, one of
which contained the complete gene as outlined in Fig. 1A, were
isolated. The gene spans a region of 10 kb and is composed
of six exons. A 5.36-kb ScaI genomic fragment that was present
in both isolated mHR6A clones was selected. This fragment
contains the first three exons, including the start codon ATG of
the ORF. A dominant-selectable neomycin resistance marker
was inserted by using the SalI and the BamHI restriction sites.
In this way, the ORF was disrupted immediately after the start
codon (Fig. 1A). In addition, amino acids 3 to 14 were deleted,
thereby strongly reducing the possibility that an aberrant pro-
tein might be formed. Transfection of the targeting construct
by electroporation and selection for stable integration of the
dominant marker resulted in a frequency of targeted, single
integrations of 2.8% (4 out of 146 analyzed), as confirmed
by Southern blot analysis. Hybridization with the 3 external
probe visualized a large EcoRI fragment of 23.6 kb in the case
of the wild-type allele and a 7.3-kb EcoRI fragment for a
targeted allele (Fig. 1B).
Generation of mHR6A-deficient mice. Two of the targeted
ES clones (clones 49 and 102) had a correct karyotype and
were used for injection into C57Bl/6 blastocysts to generate
chimeras. Four chimeras were obtained, but only one (from
clone 49) transmitted the mutated allele as determined by coat
color and Southern blot analysis with the 3 probe (data not
shown). Because the mHR6A gene, like the human ortholog,
is located on the X chromosome (34, 56), the male chimera
transmits the targeted allele only to female pups of the F1
offspring. Indeed, all of the F1 females that had the coat color
associated with the 129Sv/FVB hybrid genomic background
were heterozygous.
Next, the F1 males and females were bred, resulting in a
large number of knockout (mHR6A/Y) male mice in the F2
offspring. The absence of a functional mHR6A allele in these
animals was confirmed by RT PCR with total RNA isolated
from testis material of an mHR6A/Y animal and a wild-type
animal. No mHR6A transcripts spanning the (partially) deleted
exon 1 could be detected in testis cDNA from the mHR6A/Y
mouse, while a product of the right size (420 nucleotides) was
readily amplified from testis cDNA of the wild-type male (Fig.
1D). This finding indicates that targeted integration of the
knockout construct resulted in the absence of the original
transcripts containing the complete ORF as well as any alter-
natively spliced mRNAs.
mHR6A-deficient mice and embryonic fibroblasts. A pro-
gram of breeding between mHR6A/ females and mHR6A/Y
males was set up. The offspring showed a Mendelian represen-
tation of knockout and heterozygous female animals (91 and
91 animals, respectively) but a significant underrepresentation
of knockout male animals compared to wild-type males (71
and 116 animals, respectively) (	2 test, P 
 0.001).
To compare the body weights of the different genotypes,
litters that contained animals with both male and/or both fe-
male genotypes were included in a paired t test analysis. Mice
were weighed at the time of tailing (10  1 days after birth).
The average body weight of all animals with the same genotype
and sex within one litter was determined and included in the
analysis. On average, the body weight of knockout male and
female mice at 10 days of age was significantly lower (paired
t test, P  0.01), showing a reduction of approximately 12%
FIG. 2. Paired t test of the difference between total body weights of mice with a specific genotype and control littermates 10 1 days after birth.
Each dot represents the average body weight of all animals with a specific genotype present in one litter. The mean body weights are indicated
by horizontal bars. The asterisks indicate statistically significant differences between the indicated groups (P 0.05). N is the number of litters used
in the analysis. (A) Total body weights of mHR6A-deficient animals and control littermates. Included are litters that contain both mHR6A/Y and
mHR6A/Y male mice and/or both mHR6A/ and mHR6A/ female mice. (B) Total body weights of mice with one single functional mHR6B
allele and control littermates. Included are only litters that contain both mHR6A/Y/mHR6B/ and mHR6A/Y/mHR6B/ male animals and/or
both mHR6A//mHR6B/ and mHR6A//mHR6B/ female animals. The genotypes of both genes are indicated under the x axis.
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compared to that of the respective control littermates (Fig.
2A).
To investigate the possible occurrence of pathological ab-
normalities, most organs of three adult knockout animals and
three control littermates were fixed and hematoxylin and eosin
stained, but no aberrations were found (data not shown).
In view of the role of the RAD6 protein in RDB in yeast,
mHR6A-deficient MEF cell lines were tested for their growth
rates and cellular survival after irradiation with different doses
of UV, as measured by [3H]thymidine incorporation. No dif-
ferences between mHR6A-deficient and mHR6A-proficient
cell lines were observed (data not shown). This finding dem-
onstrates that UV resistance in mHR6B-deficient cells (55)
does not depend on a functional mHR6A allele but is presum-
ably caused by redundant activities of mHR6A and mHR6B in
somatic cell types.
mHR6A/Y males are normally fertile, but mHR6A/ fe-
males are not able to produce offspring. In contrast to the
phenotype observed in mHR6B knockout mice, whereby fe-
males are normally fertile and males are sterile, we observed
the reverse for mHR6A-deficient animals; mHR6A/Y male
mice were normally fertile, as shown by their ability to sire
litters (Table 1) as well as by a precise analysis of male repro-
ductive parameters (data not shown), but mHR6A/ female
mice appeared infertile. We investigated whether these fe-
males were receptive to mating with both mHR6A/Y and
wild-type males. Successful matings, indicated by the presence
of copulatory plugs, were observed in mHR6A/ females re-
gardless of which males were used. The numbers of pups per
litter that resulted from the breeding of heterozygous females
with wild-type and knockout males were not significantly dif-
ferent (P
 0.81, two-tailed Student’s t test). Ovaries were then
isolated from knockout and heterozygous littermates, fixed,
sectioned, stained, and microscopically analyzed for the pres-
ence of the various stages of follicular development. Ovaries
from mHR6A/ females appeared indistinguishable from
those of mHR6A/ littermates, with the presence of a normal
number of growing follicles and corpora lutea (data not
shown). This finding indicates that the ovaries of mHR6A-
deficient females are capable of follicular development and
ovulation. To follow up on the initial observation, we super-
ovulated mHR6A/ and mHR6A/ females and housed
them overnight with FVB/n wild-type males. Fertilized oocytes
were recovered from the oviducts and cultured in vitro. The
one-cell embryos recovered from mHR6A/ females ap-
peared morphologically normal and comparable with the em-
bryos isolated from the heterozygous control females. All of
the embryos contained two pronuclei (Fig. 3A to D), indicating
that they were normally fertilized and did not develop parthe-
nogenetically after fertilization with wild-type sperm. The one-
cell embryos recovered from mHR6A/ and mHR6A/ fe-
males developed up to the two-cell stage in vitro but were not
able to overcome a two-cell-stage block. This situation is not
unusual for noninbred strains (22) but prevented us from de-
FIG. 3. Developmental stages of preimplantation embryos ob-
tained from mHR6A/ (A, B, E, and F) and mHR6A/ (C, D, G, and
H) female mice fertilized by wild-type males. Images obtained with
confocal laser scanning microscopy (A to D) show embryos from an
mHR6A/ heterozygous mother (A and B) and an mHR6A/ knock-
out mother (C and D) approximately 8 h after fertilization. Two planes
are displayed for the fertilized egg, one showing the paternal pronu-
cleus (P in panels A and C) and one showing the maternal pronucleus
(M in panels B and D). Phase-contrast microscopy shows examples of
embryos obtained from mHR6A/ (E and F) and mHR6A/ (G and
H) female mice at 1.5 dpc (E and G) and cultured for 3 days (F and H).
(E) Embryos at various stages of development, obtained from an
mHR6A/ female. (F) Hatching (left) and hatched (upper right)
embryos and an empty zona pellucida (lower right). (G) Embryos
obtained from an mHR6A/ female. (H) One-cell (left), two-cell
(upper right), and fragmented (lower right) embryos. Scale bar, 20 m.






Litter size (mean no.
of pups  SD)
/  /Y NDa
/  /Y 7 5.9  2.6
/  /Y 35 8.7  2.6
/  /Y 79 8.6  2.7
/  /Y 11 0
/  /Y 13 0
a ND, not determined.
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termining the end point of the development of embryos de-
rived from an mHR6A/ mother. Therefore, embryos were
recovered by flushing the oviducts 1.5 dpc, when developing
embryos are at the two-cell stage, and subsequently these em-
bryos were cultured for three additional days before reexami-
nation. Total numbers of 37 two-cell embryos and 1 four-cell-
stage embryo were recovered from four mHR6A/ females,
and all of these embryos appeared normal (Fig. 3E). All two-
cell and four-cell embryos developed into blastocysts, most of
which started hatching, and some of these embryos were al-
ready completely hatched, leaving behind an empty zona pel-
lucida (Fig. 3F). From four mHR6A/ females, 13 phenotyp-
ically normal two-cell-stage embryos, 2 two-cell-stage embryos
with cytoplasmic fragments, 11 fertilized oocytes (of which 5
showed signs of fragmentation), and 1 three-cell embryo were
retrieved (Fig. 3G). None of these embryos isolated from the
oviducts of the mHR6A/ females grew out to the blastocyst
stage. Eight of them reached or remained in the two-cell stage,
and others remained unicellular or showed severe cytoplasmic
fragmentation and degeneration (Fig. 3H). This result was not
a culture artifact, since embryos isolated at 3.5 dpc from
mHR6A/ female mice were also found to have developed no
further than the two-cell stage (data not shown). This finding
points to an important role of maternal mHR6A in the very
early stages of embryonic development.
The mHR6A protein level is high compared to that of
mHR6B in oocytes. In a number of tissues and cell types that
were analyzed, the levels of mHR6A and mHR6B were com-
parable (32). In the testis, the postmeiotic cells, the spermatids,
showed a relative increase of mHR6B compared to mHR6A
(6, 32). This increase might be caused by the inactivation of the
X-chromosomal mHR6A gene in spermatogenesis, when the X
and Y chromosomes form the heterochromatic sex body dur-
ing the meiotic prophase (62). In oogenesis, the two X chro-
mosomes are transcriptionally active during the meiotic
prophase, which might result in a relatively high level of
mHR6A compared to mHR6B (35). To test this possibility, we
first prepared protein extracts from ovaries of wild-type and
mHR6A heterozygous and knockout mice. The protein con-
tents of these samples were separated by two-dimensional gel
electrophoresis and blotted, and mHR6A and mHR6B pro-
teins were visualized by using the -HR6A/B antibody as de-
scribed (5). This analysis confirmed the absence of mHR6A in
ovaries from mHR6A/ females (Fig. 4A) but also showed
that in the wild-type whole ovary, the levels of mHR6A and
mHR6B were about equal. Differential expression of the two
proteins in oocytes may go undetected when whole ovary tissue
is analyzed. Hence, to determine the relative levels of mHR6A
and mHR6B proteins in wild-type oocytes, oocyte maturation
was induced in six female mice by injecting the mice with 5 IU
of Folligonan. Approximately 240 oocytes were isolated, lysed,
and analyzed by two-dimensional gel electrophoresis. It was
found that the level of mHR6A in isolated oocytes was rela-
tively high compared to that of mHR6B (Fig. 4B).
Methylation of histone H3 in pronuclei in wild-type and
FIG. 4. mHR6A and mHR6B protein expression. Total protein extracts were separated by using two-dimensional gel electrophoresis. (A) Com-
parison of the amounts of mHR6A and mHR6B proteins (indicated by “A” and “B,” respectively) in ovaries from mHR6A/, mHR6A/, and
mHR6A/ mice. (B) Expression of mHR6A and mHR6B in oocytes isolated from wild-type mice compared to the amounts of the two proteins
in whole ovaries.
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mHR6A-deficient oocytes. In the very early stages of mamma-
lian development, dramatic epigenetic changes that are in-
volved in spatial and temporal control of gene expression occur
(3, 16, 45, 58). These changes include demethylation and de
novo methylation of CpG dinucleotide sequences. In addition,
much recent evidence shows that epigenetic histone modifica-
tions are tightly regulated to assure control of gene expression
but also DNA repair and recombination (for a review, see
reference 18). Recently, it was shown that Saccharomyces cere-
visiae RAD6 plays an important role in the posttranslational
modification of histones. Monoubiquitination of histone H2B
at lysine 123 is a prerequisite for the methylation of lysine 4 of
histone H3 (H3K4) (16, 65), a modification that is associated
with active gene expression, cell growth, telomeric and ribo-
somal DNA silencing, and sporulation (10, 57, 64). In higher
eukaryotes, H3K4 methylation is associated with active chro-
matin domains, whereas methylated H3K9 associates with het-
erochromatic subdomains and gene silencing (reviewed in ref-
erence 38). Using specific antibodies against methylated H3K4
and methylated H3K9, we analyzed the role of mHR6A in
controlling the methylation status of histone H3 during fertil-
ization and early embryonic development. Embryos were iso-
lated approximately 12 and 36 h postcoitum from mHR6A/
and mHR6A/ females. At 12 h postcoitum, immunofluores-
cent staining for H3K9 was predominantly associated with the
maternal pronucleus (data not shown), a finding that is in full
agreement with earlier data (3, 13). Two-cell embryos, isolated
36 h postcoitum, show clear and overall staining of the nuclei
of both blastomeres irrespective of the genotype of the mother
(data not shown). This finding suggests that H3K9 methylation
is not severely affected by the absence of mHR6A during the
formation of the first two blastomeres. In a similar experiment,
it was observed that methylated H3K4 was also predominantly
associated with the maternal pronucleus in one-cell embryos
obtained from mHR6A/ females (Fig. 5A), and no overt
difference was observed for one-cell embryos from the mHR6A
knockout females (Fig. 5C). After the first cell division, both
nuclei fluoresce with similar intensities irrespective of the ge-
notype of the mother (Fig. 5E and G). Immunofluorescent
staining of one- and two-cell embryos for histone H3 clearly
demonstrates the presence of histones in both pronuclei at this
stage (data not shown). These data suggest that there are no
marked changes in the methylation status of histone H3 in
early embryos that can be attributed to the absence of maternal
mHR6A.
Mice with losses of mHR6A and mHR6B alleles. The severe,
pleiotropic phenotype of a rad6-null yeast strain (for a review,
see reference 40), compared to the relatively mild phenotype
that results from either mHR6A or mHR6B deficiency, sug-
gests a strong functional redundancy between these two pro-
teins. To investigate the effect of the complete loss of both
RAD6 homologs in mice, a breeding program was set up to
obtain double-knockout (DKO) animals. In this breeding pro-
gram, double heterozygosity has no gross deleterious effect on
embryonic development, and mHR6A//mHR6B/ female
mice were mated with mHR6A/Y/mHR6B/ males. As
shown in Table 2, no DKO animals were found, whereas ap-
proximately 11 DKO mice were to be expected (	2 test, P 
0.001). In addition, female mHR6A//mHR6B/ animals
were also absent. This result is most likely due to random
inactivation of the X chromosome early in development,
thereby leaving only 50% of the cells in these mHR6B-defi-
cient mice with one functional wild-type X-chromosomal
mHR6A allele.
With the exception of mHR6A/Y/mHR6B/ animals (no
functional allele) and the mHR6A//mHR6B/ mice (only
one intact allele, which is subject to X inactivation), all of
the other genotypes were represented in the offspring. Mice
FIG. 5. Immunofluorescent images of one-cell (A to D) and two-cell (E to H) embryos stained with an antibody against methylated H3K4 (A,
C, E, and G) and DAPI (B, D, F, and H). The genotype of the mother is indicated on the right. The intense bright spots in panels C to H are caused
by the remnants of a polar body. Staining of only one of the two pronuclei with -methylated H3K4 is observed (A and C), while both nuclei of
the two-cell embryo stain equally intensely (E and G).
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lacking an intact mHR6A allele and being heterozygous for
mHR6B (mHR6A/Y/mHR6B/), however, were clearly un-
derrepresented (	2 test, P  0.025) and showed a pronounced
decrease in body weight that was already visible at birth. To
investigate this result in more detail, mHR6A//mHR6B/
females were mated with mHR6A/Y/mHR6B/ males and
the offspring were genotyped and weighed. Mice that con-
tained only one wild-type mHR6B allele were significantly un-
derrepresented in the offspring (	2 test, P  0.001) (Table 2).
To quantify the loss of body weight, we compared the body
weights of wild-type versus mHR6A/Y/mHR6B/ males
and those of mHR6A//mHR6B/ versus mHR6A//
mHR6B/ females. Only litters that contained pups with
both male and/or both female genotypes were included. The
average body weights of mHR6A/Y/mHR6B/ male and
mHR6A//mHR6B/ female animals at 10 days of age were
significantly lower (paired t test, P  0.01) than those of the
control littermates, with a reductions of 37 and 31%, respec-
tively (Fig. 2B). Interestingly, mHR6A/Y/mHR6B/ male an-
imals were found to be normally fertile. The average number
of pups per breeding sired by these males was not significantly
lower then that of pups sired by mHR6A/Y/mHR6B/ males
(P 
 0.387, two-tailed Student’s t test) mated with mHR6A//
mHR6B/ females (7.1  2.7 and 7.6  2.6 pups, respec-
tively). This result indicates that, in the testis, the level of
mHR6B protein from one intact and functional allele can
compensate for the complete loss of mHR6A and/or that
mHR6B has a specific function in spermatogenesis.
DISCUSSION
Over the last few years, a number of mammalian homologs
of yeast RDB genes that exhibit a high degree of sequence and
functional conservation have been identified, suggesting that
RDB mechanisms might be conserved throughout eukaryotic
evolution (21, 30, 33, 42, 44, 47, 68, 72, 78–80). However, some
remarkable functional differences between yeast and mamma-
lian proteins (8, 17, 73, 76) and the identification of additional
Y family DNA polymerases in mammalian species (for a re-
view, see reference 19) forbid simple extrapolation from yeast
to mammals. Also, the identification of two mammalian RAD6
homologs provides a complicating factor. Previously, we dem-
onstrated that the inactivation of the mHR6B gene, one of the
two mammalian homologs of yeast RAD6, induces only a rel-
atively mild phenotype in mice compared to that induced by a
rad6-null allele in yeast. Whereas yeast rad6 mutants display
extreme sensitivity to all kinds of genotoxins, low growth rates,
and impaired sporulation, the main phenotype of mHR6B/
mice is a severe derailment of spermatogenesis (55). This ob-
servation raised the question whether the second homolog,
mHR6A, is responsible for the greater part of the somatic
RAD6-like functions in mice or whether there is extensive
functional redundancy between the two mammalian proteins.
RAD18 is the E3 that interacts with RAD6 in RDB in yeast.
Both human RAD6 homologs can interact with human
RAD18, and the overexpression of a dominant-negative hu-
man RAD18 gene results in increased UV sensitivity (68, 79).
Analysis of mHR6A-deficient MEFs, however, failed to reveal
any difference between their response to UV irradiation and
that of wild-type cells. This outcome is comparable with results
of UV survival assays of mHR6B-deficient MEFs, which also
showed no increased UV sensitivity (55). In addition, mHR6A-
deficient mice appeared normal, apart from a slight reduction
in body weight, and preliminary studies did not reveal an in-
creased cancer predisposition up to 1 year of age.
Besides RAD18, UBR1 is another E3 capable of interacting
with RAD6 (15). The human and mouse homologs of UBR1
have been cloned, and their roles in the N-end rule pathway
and interaction with mHR6A and mHR6B have been con-
firmed (36, 37). One of the observed phenotypes in Ubr1/
mice is a small but significant reduction in body weight (37).
Similar reductions in body weight were observed for mHR6A-
deficient animals (present data) and for mHR6B-deficient
animals (unpublished data). Ubr1/ mice are, however,
normally fertile. This finding indicates that the infertility
phenotype of both mHR6B/ male and mHR6A/ female
mice is not determined by the interaction of mHR6A and/or
mHR6B with Ubr1 and does not involve dysregulation of pro-
tein degradation via the N-end rule.
In the present breeding program, in addition to the absence
of DKO mice, we found that mHR6A//mHR6B/ females
and mHR6A/Y/mHR6B/ males were underrepresented
and runted and often died around birth. The mHR6A/Y/
mHR6B/ males that survived were normally fertile. This
finding indicates that the level of mHR6B protein obtained
from one functional mHR6B allele is sufficient to support sper-
matogenesis, even in the absence of mHR6A protein. On the
one hand, the results obtained indicate that mHR6A and
mHR6B have completely redundant activities both in somatic
cell types and in germ line cells. On the other hand, the ob-
served female and male infertility phenotypes in mHR6A- and
mHR6B-deficient mice, respectively, indicate that germ line
cells are subject to a dose-dependent effect which involves
spermatogenesis- and oogenesis-specific differences in expres-
sion levels of mHR6A and mHR6B. However, the possibility
that mHR6A and mHR6B have different functional properties
TABLE 2. Possible genotypes and observed numbers of pups with
genotypes for various parental combinations
Genotype













A//B/ 11 (11) 75 (59) 7 (9) 30 (17)
A//B/ 20 (22) 70 (59) 11 (9) 56 (34)
A//B/ 0 (11) 0 (17)
A//B/ 61 (59) 8 (9) 16 (17)
A//B/ 16 (59) 3 (9) 20 (34)
A//B/ 0 (17)
A/Y/B/ 12 (11) 87 (59) 11 (9) 27 (17)
A/Y/B/ 37 (22) 83 (59) 15 (9) 54 (34)
A/Y/B/ 17 (11) 29 (17)
A/Y/B/ 16 (11) 60 (59) 10 (9) 24 (17)
A/Y/B/ 11 (22) 23 (59) 6 (9) 11 (34)
A/Y/B/ 0 (11) 0 (17)
Total 177 475 73 267
a A, mHR6A; B, mHR6B. Boldface numbers are significantly lower than the
expected numbers.
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at the molecular level cannot be completely excluded. Several
observations that point in this direction have been described.
Ubiquitin-protein ligases (E3s) can be found among proteins
that contain either HECT or RING motifs, such as RAD18
and UBR1 (reviewed in reference 51), but also among proteins
with U-box domains. Hatakeyama et al. (23) showed that the
U-box motif-containing cyclophilin CYC4/hCyP-60 needs the
E2 enzyme HR6B, but not HR6A, for polyubiquitination. Cy-
clophilins are thought to have chaperone functions, being in-
volved in the proper folding of protein substrates in vivo.
Although ubiquitously expressed, transcript levels of cyclophi-
lins are elevated and differ in size in the testis (74). This finding
suggests the possibility that the spermatogenic derailment ob-
served in mHR6B/ but not in mHR6A/Y males is not
caused by the relatively low level of mHR6A but by the inabil-
ity of mHR6A to interact with cyclophilin. Additional data on
possible specificity come from the identification of mHR6A,
and not mHR6B, as an interacting partner of Rfpl4 in a yeast
two-hybrid screen (67). Rfpl4 is present in maturing oocytes
and remains expressed up to the eight-cell-stage embryo in the
mouse. The protein shows the characteristics of a RING do-
main containing E3 ubiquitin ligase and can specifically inter-
act with mHR6A. This protein could be useful in trying to
identify the specificity-determining amino acid residues of
mHR6A and mHR6B; mHR6A and mHR6B differ in only
seven positions.
The most prominent effect of disrupting mHR6A is the ob-
served complete failure of mHR6A-deficient females to pro-
duce offspring, resulting from developmental arrest after the
first embryonic cell division. It is unlikely that the phenotype of
the female mHR6A/ mice is due to aberrant levels of go-
nadotropins, since vaginal smears for mHR6A-deficient fe-
males revealed regular 4- to 5-day cycles and histological ex-
amination of fixed and stained ovary sections showed the
presence of all stages of follicular development. In addition,
the animals mated readily, the number of fertilized oocytes was
similar to that for mHR6A/ littermates, and pseudopreg-
nancy was induced. These data indicate a normal hypotha-
lamic-hypophyseal-gonadal axis. Measurable deviations from
normal serum gonadotropin levels would have resulted in dys-
regulated cycles.
The present results identify mHR6A as one of the few mam-
malian genes that encode a factor essential for the very first
steps in embryonic development. Thus far, only Mater and Zar1
have been shown to encode proteins that have their major, if
not exclusive, functions in early postfertilization development
(12, 70).
The mechanism that is disrupted by the absence of mHR6A
is still unclear but could be related to the regulation of tran-
scription and/or chromatin rearrangements. Just recently, it
has started to become clear how, and what kind of, core his-
tone tail modifications play a role in chromatin remodeling,
higher-order chromatin structure, and transcription (see refer-
ence 63 and references therein). These modifications include
phosphorylation, acetylation, methylation, and ubiquitination.
Robzyk et al. (54) showed that the ubiquitination of histone
H2B in yeast is dependent on a functional RAD6 gene. Muta-
tion of lysine residue 123 of H2B, which is essential for ubiq-
uitination, prevents the methylation of H3K4 and induces
defects in sporulation and gene silencing. Other RAD6-
dependent processes, such as RDB, appear unaffected (54).
During fertilization, the chromatin in the paternal pronu-
cleus is reorganized, with histones of maternal origin replacing
protamines. From that point on, acetylated forms of histone
H4 are detectable in the paternal pronucleus, associated with
the onset of transcription (1, 2). The methylation of histone H3
at lysine residue 9 (H3K9), known to be involved in the for-
mation of stable repressive heterochromatin (50), was found in
the maternal pronucleus but could hardly be detected in the
paternal pronucleus (3, 13). In addition, H3K4 methylation, a
hallmark of active chromatin (64), was also observed predom-
inantly in the maternal pronucleus rather than the paternal
pronucleus. The antibody used in the present study recognizes
the dimethylated form of H3K4. The presence of trimethylated
H3K4 has been shown to be a prerequisite for active genes, and
the role of dimethylated H3K4 in mammalian cells is not clear,
but the presence of dimethylated H3K4 may correlate with a
permissive state of chromatin in which genes are potentially
active (59, 60). The observed H3K4 staining in the maternal
pronucleus may mark regions that will become active shortly
after the pronuclear stage. However, we did not observe a
change in the histone H3 methylation pattern in the pronuclei
in the mHR6A-deficient oocytes during fertilization.
Both mHR6A and mHR6B cDNAs encode proteins that are
able to induce H2B ubiquitination and subsequent methylation
of H3K4 in rad6 mutants (65), but there is a clear difference
between ubiquitination of H2B in yeast and that in humans. In
yeast, ubiquitinated H2B is most abundant and ubiquitinated
H2A is undetectable, whereas in human somatic cells about
10% of H2A and only 1 to 1.5% of H2B is ubiquitinated (75).
In spermatogenesis, no change in histone ubiquitination pat-
terns has been detected in mHR6B knockout testis (5), but this
result does not exclude the possibility of a low, but functionally
significant, rate of H2A and/or H2B ubiquitination by mHR6B.
Similarly, the possibility that the ubiquitin-conjugating enzyme
mHR6A takes part in chromatin remodeling during early em-
bryonic development through low rates of ubiquitination of
H2A and/or H2B, which then might affect the methylation of
histone H3 in a manner which has not been detected in the
present experiments, cannot be excluded. Finally, it is impor-
tant to note that the ubiquitination of H2B by RAD6 in yeast
appears to be unrelated to RDB mechanisms (54) and that the
role of mHR6A as a maternal factor for early embryonic de-
velopment might involve a molecular mechanism of action
outside the context of DNA repair.
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